NDA 206575 describes CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE, which is a drug marketed by
Actavis Labs Ut Inc,
Chartwell Rx,
Encube,
Glenmark Pharms,
Mylan Pharms Inc,
Padagis Israel,
Taro, and
Zydus Pharms, and is included in fifteen NDAs. It is available from
twelve suppliers. Additional details are available on the
CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE profile page.
The generic ingredient in CLINDAMYCIN PHOSPHATE AND BENZOYL PEROXIDE is
benzoyl peroxide; clindamycin phosphate. There are seventeen
drug master file entries for this compound. Fourteen
suppliers are listed for this compound. Additional details are available on the
benzoyl peroxide; clindamycin phosphate profile page.